Oltmans Curtis Gale

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return0%0%0%0%0%
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return(17%)(21%)0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Fulcrum Therapeutics, Inc.

Other » Other

Chief Legal Officer:

Holdings: 1.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Array BioPharma, Inc.

Other » Other

General Counsel:

Holdings: 15.02K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Avenue Therapeutics, Inc.

Other » Other

Director:

Holdings: 49.02K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--